Urinary concentrations of monohydroxylated polycyclic aromatic hydrocarbons in adults from the U.S. Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013–2014)
Individual Clinical
Pharmacokinetics
& Abuse Liability
Pharmacokinetics
Wang (2019)
Poisoning exposure cases involving e-cigarettes and e-liquid in the United States, 2010-2018.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Wang (2020)
Dysregulated Metabolites Serve as Novel Biomarkers for Metabolic Diseases Caused by E-Cigarette Vaping and Cigarette Smoking.
Individual Clinical
Biomarkers
Biomarkers Of Harm
Wang (2021)
Trends and characteristics of ocular exposures related to e-cigarettes and e-liquids reported to Poison Control Centers in the United States, 2010-2019.
Individual Clinical
Safety
Adverse Effects
Wang (2022)
Trends in Nicotine Strength in Electronic Cigarettes Sold in the United States by Flavor, Product Type, and Manufacturer, 2017-2022.
Individual Clinical
User Topography
Wang (2023)